Detalhe da pesquisa
1.
Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.
J Neurooncol
; 129(1): 131-8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27287856
2.
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.
Prostate
; 75(8): 836-44, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683285
3.
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.
J Clin Oncol
; 33(34): 4007-14, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26324372